CNVVY vs COGT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CNVVY · CONVATEC GROUP PLC UNSP ADR EACH REP 4 ORD SHS$13.37 ▼ 2.19%
COGT · Cogent Biosciences$31.65 ▲ 6.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CNVVY +9.0%
- COGT -2.5%
Head to head
| Metric | CNVVY | COGT |
|---|---|---|
| Price | $13.37 | $31.65 |
| Change today | ▼ 2.19% | ▲ 6.98% |
| Market cap | $5.50B | $5.49B |
| Return, 3 months | +6.3% | -23.8% |
| Return, year to date | +4.7% | -10.9% |
| Return, 1 year | +11.7% | +113.5% |
| P/E (TTM) | 53.5 | – |
| P/B | 4.6 | 12.2 |
| P/E percentile vs own 5y | – | 18th |
| Dividend yield | 2.23% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | -31.1% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | -146.5% |
| Analyst target vs. price | – | +73.4% |
| Analyst buy share | – | 89% |
| RSI (14) | 62 | 52 |
| 30-day volatility | 25.4% | 47.6% |
| Max drawdown, 1 year | -23.6% | -34.4% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CNVVY is the largest of the group by market value.
- COGT has returned the most over the past year.
- CNVVY has been the calmest stock over the last 30 days.